Arrowhead Research | ARWR - Trade Creditors


Arrowhead Research reported $17.67M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 19.55M 2.02M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Arrowhead Research USD 17.67M 15.38M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ligand Pharmaceuticals USD 27.76M 1.72M Sep/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 267M 92M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025
Xencor USD 9.08M 9.45M Sep/2025